搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
FierceBiotech
23 分钟
AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator
AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...
Pharmaceutical Technology
4 小时
AbbVie and Richter partner for neuropsychiatric treatments
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
1 小时
Argent Capital Management LLC Has $761,000 Stock Position in AbbVie Inc. (NYSE:ABBV)
Argent Capital Management LLC reduced its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 96.3% in the 3rd quarter, ...
1 天
AbbVie: Expect A Beat-And-Raise Q3 2024
AbbVie should report strong Q3 2024 results next week and increase the full-year guidance. Explore more details here.
20 小时
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of ...
AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
3 天
AbbVie: Strong Dividends But Humira Disappoints
Valuation metrics show AbbVie to be only slightly undervalued based on FY 2025 projections. Read why I'm neutral on ABBV ...
14 小时
AbbVie (ABBV) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, AbbVie (ABBV) stood at $189.65, denoting a +0.94% change from the preceding trading day.
Zacks.com on MSN
1 天
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
PharmTech
15 小时
FDA Approves AbbVie Therapy for Adults with Advanced Parkinson’s Disease
Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.
6 天
on MSN
Analysts revise AbbVie stock price target ahead of earnings
Related: Analyst revises AbbVie stock price target on drug-sale estimates Sales eroded, however, as Humira faced competition ...
2 天
With 73% institutional ownership, AbbVie Inc. (NYSE:ABBV) is a favorite amongst the big guns
Failed to import article template. Reason: Failed to fetch dynamically imported module: ...
20 小时
AbbVie和Richter扩大中枢神经系统合作伙伴关系,达成新协议
伊利诺伊州北芝加哥 - 艾伯维公司(纽约证券交易所代码:ABBV)和Gedeon Richter Plc.宣布达成协议,共同发现和开发治疗神经精神疾病的新疗法。这项合作建立在近20年的合作伙伴关系基础之上,该合作关系已经产生了中枢神经系统疗法,包括cariprazine(VRAYLAR® / REAGILA®)和研究中的药物ABBV-932。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈